News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

FemmePharma, Inc. CEO To Be Honored At 4th Annual Regional Biotech Council Conference

10/19/2005 5:11:29 PM

WAYNE, Pa., Sept. 20 /PRNewswire/ -- The Regional Biotech Council, established in rural Bucks County in 2000, will hold its 4th Annual Regional Biotech Council Conference at the Pinecrest Country Club in Lansdale, PA on Friday, September 24, 2004. Co-hosted by Senator Joe Conti, Majority Policy Chairman and State Senator for the 10th Senatorial District, the event's theme is "Taking small and emerging biotechs through clinical trials and the complex of regulatory requirements -- a risky and expensive endeavor for all parties involved."

Gerianne Tringali DiPiano is being honored for leading her company, FemmePharma, Inc., through the rigors of drug development in the arena of women's health.

"Gerianne's story is that of an entrepreneur who stayed the course and achieved success. She is a strong example to showcase for the Conference," said Carolyn d'Arville, Ph.D., Associate Director of the Council.

"I am truly honored by this recognition and I look forward to sharing my story and experience in the hopes it will help other entrepreneurs in the region," stated Ms. Tringali DiPiano.

Focusing entirely on women's health, FemmePharma has products in late stages of development for the treatment of endometriosis, urinary incontinence and mastalgia. Recent Phase 2 clinical trials for FemmePharma's endometriosis product yielded a significant decrease in the reduction of pain associated with the disease and an absence of systemic side effects for those who participated in the trial.

About FemmePharma, Inc.

FemmePharma was founded by Gerianne Tringali DiPiano in 1996 to target needs within the estimated $70 billion women's healthcare pharmaceutical market. The Company is in a Phase III trial for FP1096, a new investigational treatment for endometriosis, and is preparing for its Phase II trial for its drug to treat female urinary incontinence. FemmePharma is devoted to developing safe and effective drugs that minimize or eliminate unpleasant side effects associated with many medications by designing them in a manner that is specifically suited to a woman's physiology, with an eye toward the changing needs of women throughout their lives. The company has a number of drugs in development based on its proprietary technologies, including a new therapeutic option for mastalgia. For more information about FemmePharma, please visit its website at .

About Regional Biotech Council

The mission of The Regional Biotech Council, established in rural Bucks County in 2000, is to provide a networking environment, with a regional emphasis, for biotech entrepreneurs as well as small and emerging biotech companies to support their concerns on organizational and strategic issues, thereby helping the biotechnology community leverage bargaining power, and become stakeholders in their own future in Southeastern Pennsylvania. The Council, which serves the five counties: Chester, Montgomery, Delaware, Philadelphia and Bucks, welcomes the more established companies to meetings, where a wealth of experience in biotech can be shared and strategic networking relationships can be fostered and maintained.

FemmePharma, Inc.

CONTACT: Kim Groff, +1-610-995-0801, or Rachael Schwartz,+1-215-873-0378, both for FemmePharma, Inc.

Read at

comments powered by Disqus